Business Description
Immuron Ltd
ISIN : AU000000IMC7
Compare
Compare
Traded in other countries / regions
IMC.AustraliaIMRN.USAANW.Germany IPO Date
2017-06-14Description
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 86.87 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.68 | |||||
| Beneish M-Score | -2.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -17 | |||||
| 3-Year EPS without NRI Growth Rate | 2 | |||||
| 3-Year FCF Growth Rate | 15.1 | |||||
| 3-Year Book Growth Rate | 39 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.77 | |||||
| 9-Day RSI | 42.66 | |||||
| 14-Day RSI | 47.4 | |||||
| 6-1 Month Momentum % | 22.99 | |||||
| 12-1 Month Momentum % | 15.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.52 | |||||
| Quick Ratio | 7.79 | |||||
| Cash Ratio | 7.38 | |||||
| Days Inventory | 322.26 | |||||
| Days Sales Outstanding | 19.18 | |||||
| Days Payable | 281.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.5 | |||||
| Shareholder Yield % | 0.05 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.8 | |||||
| Operating Margin % | -80.24 | |||||
| Net Margin % | -108.5 | |||||
| FCF Margin % | -101 | |||||
| ROE % | -19.93 | |||||
| ROA % | -17.92 | |||||
| ROIC % | -100.83 | |||||
| ROC (Joel Greenblatt) % | -1736.32 | |||||
| ROCE % | -19.74 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6.67 | |||||
| PB Ratio | 1.3 | |||||
| Price-to-Tangible-Book | 1.3 | |||||
| EV-to-EBIT | -1.03 | |||||
| EV-to-EBITDA | -1.03 | |||||
| EV-to-Revenue | 1.11 | |||||
| EV-to-FCF | -1.1 | |||||
| Price-to-Net-Current-Asset-Value | 1.43 | |||||
| Price-to-Net-Cash | 1.66 | |||||
| Earnings Yield (Greenblatt) % | -97.09 | |||||
| FCF Yield % | -15.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immuron Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2.202 | ||
| EPS (TTM) (€) | -0.011 | ||
| Beta | 1.72 | ||
| Volatility % | 77.03 | ||
| 14-Day RSI | 47.4 | ||
| 14-Day ATR (€) | 0.002717 | ||
| 20-Day SMA (€) | 0.057425 | ||
| 12-1 Month Momentum % | 15.05 | ||
| 52-Week Range (€) | 0.0315 - 0.109 | ||
| Shares Outstanding (Mil) | 227.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Immuron Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Immuron Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Immuron Ltd Frequently Asked Questions
What is Immuron Ltd(FRA:ANW)'s stock price today?
The current price of FRA:ANW is €0.05. The 52 week high of FRA:ANW is €0.11 and 52 week low is €0.03.
When is next earnings date of Immuron Ltd(FRA:ANW)?
The next earnings date of Immuron Ltd(FRA:ANW) is .
Does Immuron Ltd(FRA:ANW) pay dividends? If so, how much?
Immuron Ltd(FRA:ANW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers